Nature of the Case and Issue(s) Presented: Merck owned U.S. Patent No. 6,670,340 (“the ‘’340 patent”), which issued on Dec. 30, 2003, and claimed a class of 6-mercaptocyclodextrin derivatives, ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. A press release from Merck Sharpe & ...
The Federal Circuit heard oral argument in Auribundo's appeal of the district court's decision in favor of plaintiff Merck, in a case captioned In re Sugammadex (alternatively, Aurobindo v. Merck ...
Merck Sharp & Dohme LLC has described antibody-drug conjugates (ADCs) comprising antibodies targeting tumor-associated calcium signal transducer 2 (TACSTD2; TROP2) linked to exatecan through a linker ...
Type to search articles, cases, and authors. Press ↵ to view all results. Petition for certiorari denied on June 16, 2025. Whether, if a pharmaceutical manufacturer fully informs the Food & Drug ...
Merck Sharp & Dohme Corp. (MSD), known as Merck & Co. Inc. in the U.S. and Canada, terminated its potential $1.86 billion deal with San Diego-based Artiva Biotherapeutics Inc. for novel chimeric ...
(RTTNews) - Halozyme Therapeutics (HALO) filed a patent infringement lawsuit against Merck Sharp & Dohme Corp. in U.S. District Court in New Jersey. Halozyme believes the subcutaneous formulation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results